The business alliance with Kyowa Pharmaceutical Industry Co., Ltd. (announced on June 2020, 6) was covered in multiple media.

[Web media] (Posting order. Posting date in parentheses)

ITmedia (6/3)
Kyowa Pharmaceutical Industry and FRONTEO strengthen alliance to realize “dementia diagnosis with AI” Judgment of severity from conversations between doctors and patients Aiming for regulatory approval in FY23
https://www.itmedia.co.jp/news/articles/2006/03/news127.html

Mynavi News (6/3)
Kyowa Pharmaceutical Industry and FRONTEO tie up for dementia diagnosis support AI system development and sales
https://news.biglobe.ne.jp/it/0603/mnn_200603_9795432318.html

Mix Online (6/4)
Concluded a business alliance agreement with Kyowa Pharmaceutical for FRONTEO dementia diagnosis support AI system (medical equipment)
https://www.mixonline.jp/tabid55.html?artid=69391

Nikkei Biotech (6/4)
FRONTEO, AI-equipped dementia diagnosis system "aims to obtain approval in 2023"
https://bio.nikkeibp.co.jp/atcl/news/p1/20/06/03/07040/

Daily Pharmaceutical Industry Web (6/4)
AI dementia diagnosis support system "to be introduced in half of CNS facilities" Kyowa Pharmaceutical Industry President Tsunoda presents goals
https://nk.jiho.jp/article/152112

CNET Japan (6/4)
AI supports dementia diagnosis from natural conversation – Kyowa Pharmaceutical and FRONTEO enter into a business alliance agreement
https://japan.cnet.com/article/35154752/

【newspaper】
Yakuji Nippo (6/5) p. 7
Partnership agreement with Fronteo-Support for dementia diagnosis by utilizing AI Kyowa Pharmaceutical Industry